Autosilicon Releases 24-Channel Battery Diagnosis IC for Electric Vehicles and Energy Storage Systems
SEOUL, South Korea–(BUSINESS WIRE)–#24ChannelBatteryDiagnosisIC—Autosilicon Inc. has launched 24-channel Battery Diagnosis IC (BDIC) in January... Read more.
SoftBank Ventures Asia is Newly Becoming SBVA
The New SBVA Establishes KRW 200B ($150M) Korea Venture Fund SEOUL, South Korea–(BUSINESS WIRE)–SoftBank Ventures Asia is officially changing its company... Read more.
Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery
Findings presented at STS 2024 suggest tumor-targeted fluorescent imaging agent helps surgeons see tumors in real time during minimally invasive and robotic-assisted... Read more.
Santa Clara University Celebrates History-Making $1 Billion Fundraising Milestone
University marks rare achievement at annual Golden Circle gala, highlighted by special performance from superstar John Legend SANTA CLARA, Calif.–(BUSINESS... Read more.
BTI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that British American Tobacco p.l.c. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of British American Tobacco p.l.c.... Read more.
Merck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Death by 38% Versus Placebo as Adjuvant Therapy for Patients With Renal Cell Carcinoma (RCC) at an Increased Risk of Recurrence Following Nephrectomy
KEYNOTE-564 is the first Phase 3 trial to demonstrate superior overall survival (OS) with adjuvant therapy compared to placebo in patients with RCC Late-breaking... Read more.
Subcutaneous Nivolumab (nivolumab and hyaluronidase) Shows Noninferiority Compared to Intravenous Opdivo (nivolumab) in Advanced or Metastatic Clear Cell Renal Cell Carcinoma in CheckMate -67T Trial
CheckMate -67T is the first Phase 3 trial of the subcutaneous formulation of Opdivo to evaluate and demonstrate noninferior pharmacokinetics, efficacy and safety... Read more.
CareDx Issues Statement in Patent Infringement Case
CareDx Found to Have Not Infringed on Patent ‘180 CareDx Intends to Seek Judicial Review of Decision and Monetary Damages on Patent ‘544 No Impact to Patient... Read more.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Archer-Daniels-Midland Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – ADM
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers... Read more.
Federman & Sherwood Announces Filing the First Securities Class Action Lawsuit Against Evolution AB (OTC: EVVTY), Martin Carlesund, and Jacob Kaplan
OKLAHOMA CITY–(BUSINESS WIRE)–#FedermanSherwood–Federman & Sherwood announces that on January 23, 2024 it filed a class action lawsuit in the... Read more.